Skip to content

Idoxuridine

Nucleoside Analog Antiviral — DERMATOLOGICALS

Also known as: allergan, idoxene, idoxuridin, iododeoxyuridine

OfmFDA approvedATC D06BB01ATC J05AB02ATC S01AD01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Idoxuridine is an ofm drug in the Nucleoside Analog Antiviral class catalogued in DrugCentral. It was first approved by the FDA in 1963. DrugCentral lists 2 molecular targets, including TK1 and UL23. Recorded indications include Herpes simplex keratitis.

  • Approval status: ofm (first approved 1963 by the FDA).
  • Drug class: Nucleoside Analog Antiviral.
  • Molecular targets: TK1 and UL23 (2 listed in DrugCentral).
  • Indications: Herpes simplex keratitis.
  • ATC code: D06BB01 (Antivirals).
  • Molecular formula: C9H11IN2O5; molecular weight 354.10 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Herpes simplex keratitis

Off-label uses (1)

  • Vaccinia keratitis

Mechanism & targets

Established pharmacologic classNucleoside Analog Antiviral

Molecular targets (2)

TargetGeneActionActivity
Thymidine kinase, cytosolicTK1unknownKi 7.05
Thymidine kinaseUL23unknownIC50 5.82

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1963-06-11FDA—ALLERGAN

ATC classification

ATC codeTherapeutic hierarchy
D06BB01DERMATOLOGICALS › ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE › CHEMOTHERAPEUTICS FOR TOPICAL USE › Antivirals
J05AB02ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Nucleosides and nucleotides excl. reverse transcriptase inhibitors
S01AD01SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIINFECTIVES › Antivirals

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Idoxuridine is on its molecule page.

Molecular formulaC9H11IN2O5
Molecular weight354.10 g/mol
CAS number54-42-2
InChIKeyXQFRJNBWHJMXHO-RRKCRQDMSA-N
PubChem CID5905
OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(I)C(=O)NC1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Idoxuridine used for?

DrugCentral lists the following indications for Idoxuridine: Herpes simplex keratitis.

How does Idoxuridine work?

Its molecular targets in DrugCentral include TK1 and UL23.

When was Idoxuridine first approved?

Idoxuridine was first approved by the FDA in 1963.

What drug class does Idoxuridine belong to?

Idoxuridine is in the Nucleoside Analog Antiviral class.

What is the chemical formula of Idoxuridine?

Idoxuridine has the molecular formula C9H11IN2O5 and a molecular weight of 354.10 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1963-06-11
AgencyFDA
Targets2
Indications1
FormulaC9H11IN2O5
DrugCentral ID1417
Interactive profile